Amneal Pharmaceuticals (AMRX) PT Raised to $9 at Truist Securities
Tweet
Share
E-mailGet Alerts AMRX Hot Sheet
Price: $19.81 +2.48%
Rating Summary:
8 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 13 | New: 70
Rating Summary:
8 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 13 | New: 70
Join SI Premium – FREE
Truist Securities analyst Les Sulewski raised the price target on Amneal Pharmaceuticals (: AMRX) to $9.00 (from $7.00) while maintaining a Buy rating.
You May Also Be Interested In
- Okta, Inc (OKTA) PT Raised to $235 at DA Davidson Following Oktane 2026
- Tsuruha Holdings Inc (3391:JP) (TSUSF) PT Lowered to JPY2,240 at UBS
- Everpure (P) PT Raised to $140 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
